| Literature DB >> 23114604 |
Alejandro Soto-Gutierrez1, Jason A Wertheim, Harald C Ott, Thomas W Gilbert.
Abstract
There is an ever-growing demand for transplantable organs to replace acute and chronically damaged tissues. This demand cannot be met by the currently available donor organs. Efforts to provide an alternative source have led to the development of organ engineering, a discipline that combines cell biology, tissue engineering, and cell/organ transplantation. Over the last several years, engineered organs have been implanted into rodent recipients and have shown modest function. In this article, we summarize the most recent advances in this field and provide a perspective on the challenges of translating this promising new technology into a proven regenerative therapy.Entities:
Mesh:
Year: 2012 PMID: 23114604 PMCID: PMC3484436 DOI: 10.1172/JCI61974
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808